Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
Jan. 13, 2026 Scientists tracking Earth’s water from space discovered that El Niño and La Niña are synchronizing floods and droughts across continents. When these climate cycles intensify, far-apart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback